The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Acquired hydrocele 1
RITUXIMAB Acute lymphocytic leukaemia recurrent 1
RITUXIMAB Acute lymphocytic leukaemia refractory 1
RITUXIMAB Adenovirus infection 1
RITUXIMAB Adrenal disorder 1
Rituximab Age-related macular degeneration 1
Rituximab Alveolitis 1
RITUXIMAB Alveolitis allergic 1
Rituximab Amaurosis 1
Rituximab Anaplastic thyroid cancer 1
Rituximab Angiodermatitis 1
Rituximab Ankle fracture 1
Rituximab Aortic dissection 1
RITUXIMAB Aplasia pure red cell 1
RITUXIMAB Arteriosclerosis coronary artery 1
Rituximab Arthrodesis 1
RITUXIMAB Aspergillus infection 1
RITUXIMAB Aspergillus test positive 1
RITUXIMAB Aspiration 1
RITUXIMAB Atelectasis 1

Total Records: 1,104     Number of Pages: 56